Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Diana Varghese

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Expert Opinion on Drug Safety|November 12, 2025
What is our current understanding of insulin-derived amyloidosis?Diana Varghese, Kashif M Munir, Stephen N Davis
European Journal of Clinical Pharmacology|October 28, 2022
Clinical pharmacologist from the eyes of a clinical pharmacologist: a questionnaire-based surveyManjunath Nookala Krishnamurthy, Anupama Pradosh, Diana Varghese, et al.
Statistics in Medicine|November 6, 2007
A Bayesian approach for sample size determination in method comparison studiesKunshan Yin, Pankaj K Choudhary, Diana Varghese, et al.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|February 4, 2022
Dose dependent slurred speech and laryngopharyngeal dysesthesia due to oxaliplatinDiana Varghese, Renita Castelino, Vijay Simha, et al.
Cancers|February 15, 2022
New Insights on the Genetics of Pheochromocytoma and Paraganglioma and Its Clinical ImplicationsSakshi Jhawar, Yasuhiro Arakawa, Suresh Kumar, et al.
ACS Chemical Biology|September 5, 2014
Identification of small molecule modulators of gene transcription with anticancer activityTram Anh Tran, Jennifer Wichterman-Kouznetsova, Diana Varghese, et al.
Nature Communications|June 25, 2013
A small molecule modulates Jumonji histone demethylase activity and selectively inhibits cancer growthLei Wang, Jianjun Chang, Diana Varghese, et al.
Biorxiv : the Preprint Server for Biology|October 17, 2024
Identification of DLK1, a Notch ligand, as an immunotherapeutic target and regulator of tumor cell plasticity and chemoresistance in adrenocortical carcinomaNai-Yun Sun, Suresh Kumar, Yoo Sun Kim, et al.
Nature Communications|July 2, 2025
Identification of the Notch ligand DLK1 as an immunotherapeutic target and regulator of tumor cell plasticity and chemoresistance in adrenocortical carcinomaNai-Yun Sun, Suresh Kumar, Yoo Sun Kim, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Expert Opinion on Drug Safety|November 12, 2025
What is our current understanding of insulin-derived amyloidosis?Diana Varghese, Kashif M Munir, Stephen N Davis
European Journal of Clinical Pharmacology|October 28, 2022
Clinical pharmacologist from the eyes of a clinical pharmacologist: a questionnaire-based surveyManjunath Nookala Krishnamurthy, Anupama Pradosh, Diana Varghese, et al.
Statistics in Medicine|November 6, 2007
A Bayesian approach for sample size determination in method comparison studiesKunshan Yin, Pankaj K Choudhary, Diana Varghese, et al.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|February 4, 2022
Dose dependent slurred speech and laryngopharyngeal dysesthesia due to oxaliplatinDiana Varghese, Renita Castelino, Vijay Simha, et al.
Cancers|February 15, 2022
New Insights on the Genetics of Pheochromocytoma and Paraganglioma and Its Clinical ImplicationsSakshi Jhawar, Yasuhiro Arakawa, Suresh Kumar, et al.
ACS Chemical Biology|September 5, 2014
Identification of small molecule modulators of gene transcription with anticancer activityTram Anh Tran, Jennifer Wichterman-Kouznetsova, Diana Varghese, et al.
Nature Communications|June 25, 2013
A small molecule modulates Jumonji histone demethylase activity and selectively inhibits cancer growthLei Wang, Jianjun Chang, Diana Varghese, et al.
Biorxiv : the Preprint Server for Biology|October 17, 2024
Identification of DLK1, a Notch ligand, as an immunotherapeutic target and regulator of tumor cell plasticity and chemoresistance in adrenocortical carcinomaNai-Yun Sun, Suresh Kumar, Yoo Sun Kim, et al.
Nature Communications|July 2, 2025
Identification of the Notch ligand DLK1 as an immunotherapeutic target and regulator of tumor cell plasticity and chemoresistance in adrenocortical carcinomaNai-Yun Sun, Suresh Kumar, Yoo Sun Kim, et al.
Pageof 1